Please enable JavaScript.
Coggle requires JavaScript to display documents.
Biopharmaceutical Considerations - Coggle Diagram
Biopharmaceutical Considerations
Active Pharmaceutical Ingredient (API)
Stability
Solubility
pH and pKa
Crystalline form (polymorph)
Excipient interaction & compatibility
Impurities
Salt form
Particle size
Complexation
Drug product
Type of drug product (e.g. solution, tablet, capsule, patch etc.)
Immediate or modified release
Dosage strength
Bioavailability
Stability
Excipients
Manufacturing variables
Physiologic factors
Binding to macromolecules
Route of administration
Bio-transformation
Blood flow
Permeation of drug across cell membranes
Surface area
Pharmacodynamic & Pharmacokinetic considerations
Bioavailability
Adverse reactions
Therapeutic objective
Pharmacokinetics
Dose
Toxic effects
Manufacturing considerations
Cost
Product methodology and technology
Specification of raw materials
Stability testing
Quality control/ Quality assurance
Patient considerations
Compliance
Product acceptance
Labelling
Cost